Quidel Reports Third Quarter 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Quidel Corp (QDEL) Tops Q3 EPS by 10c, Revenues Miss
November 6, 2018 4:26 PM ESTQuidel Corp (NASDAQ: QDEL) reported Q3 EPS of $0.59, $0.10 better than the analyst estimate of $0.49. Revenue for the quarter came in at $117.4 million versus the consensus estimate of $120.1 million.
Total revenue was $117.4 million as compared to $50.9 million in the third quarter of 2017.Cardiac Immunoassay revenue was $65.3 million.Influenza revenue was $21.6 million as compared to $23.1 million in the third quarter of 2017.Reported GAAP EPS of $0.27 per... More